Graybug Vision Inc GRAY:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
0.9592quote price arrow down-0.011 (-1.1338%)
Volume
11,451
52 week range
0.72 - 3.77
Loading...
  • Open0.9448
  • Day High0.99
  • Day Low0.9448
  • Prev Close0.9702
  • 52 Week High3.77
  • 52 Week High Date10/14/21
  • 52 Week Low0.72
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap20.64M
  • Shares Out21.52M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-47.58

KEY STATS

  • Open0.9448
  • Day High0.99
  • Day Low0.9448
  • Prev Close0.9702
  • 52 Week High3.77
  • 52 Week High Date10/14/21
  • 52 Week Low0.72
  • 52 Week Low Date05/12/22
  • Market Cap20.64M
  • Shares Out21.52M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-47.58

RATIOS/PROFITABILITY

  • EPS (TTM)-1.64
  • P/E (TTM)-0.58
  • Fwd P/E (NTM)-0.54
  • EBITDA (TTM)-34.684M
  • ROE (TTM)-54.62%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Graybug Vision Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Graybug Vision, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases. The Company's products include GB-102 and GB-401. GB-102 is a lead product designed to provide pan-vascular endothelial growth factor (VEGF) inhibition for six months or longer while minimizing fluctuations in retinal thickness in between treatments. GB-102 is a once-every-six month intravitreal injection for the treatment of...
Christy Shaffer Ph.D.
Independent Chairman of the Board
Frederic Guerard Pharm.D.
President, Chief Executive Officer, Director
Robert Breuil
Chief Financial Officer
Address
203 Redwood Shores Parkway, Suite 620
Redwood City, CA
94065
United States

Top Peers

SYMBOLLASTCHG%CHG
CRBP
Corbus Pharmaceuticals Holdings Inc
0.1748-0.0026-1.4656%
SIOX
Sio Gene Therapies Inc
0.2899-0.0068-2.2919%
VINC
Vincerx Pharma Inc
1.10+0.02+1.85%
ONCR
Oncorus Inc
0.852-0.0281-3.1928%
PYPD
PolyPid Ltd
1.23+0.10+8.85%